Wuhan Easy Diagnosis to Acquire 100% of Bicare Rescue Products for 190M RMB

Today, several notable announcements were made by companies listed on the Shenzhen Stock Exchange, with significant developments in acquisitions, earnings reports, and regulatory matters.

Deals & Restructuring

• Wuhan Easy Diagnosis Biomedicine Co., Ltd. (002932) intends to acquire 100% equity of Wuhan Bicare Rescue Products Co., Ltd. from Blue Sail Medical Co., Ltd. for a total cash consideration of 190 million RMB. This acquisition aims to expand the company's business scope.

• Zhaori Technology Co., Ltd. (300333) reported an equity change event where Shanghai Jingheheng Technology Co., Ltd. is acquiring 47,658,852 shares, representing 14.18% of the company's total shares, from Xinjiang Chaojun. This transaction requires further approvals.

• Guorui Technology Co., Ltd. (300600) announced progress in the strategic restructuring between its controlling shareholder, Zhejiang Light Industry Group, and Zhejiang Machinery & Electrical Group Co., Ltd. The restructuring has received provincial government approval.

• Hunan Junxin Environmental Protection Co., Ltd. (301109) updated on its H share issuance and listing on the Hong Kong Stock Exchange, confirming that its application materials have been submitted and reviewed, pending formal approval.

Earnings & Performance

• Haosai Co., Ltd. (002963) reported a net loss of 28.31 million RMB for the first half of 2026, with a 23.52% year-on-year decline in revenue. The Wuhan Intermediate People's Court has remanded a previous criminal conviction against the company for retrial, adding uncertainty to its legal standing.

• Chengxin Lithium Group Co., Ltd. (002240) received an unqualified audit opinion from Wuyige Certified Public Accountants LLP for its subsidiary, Shengxin Lithium Energy Group Co., Ltd., confirming compliance with accounting standards.

• Huarong Chemical Co., Ltd. (301256) released its interim report, highlighting ongoing losses in its chlorine product segment and proposing a profit distribution plan of 0.30 RMB per 10 shares.

Regulatory & Governance

• ST United Co., Ltd. (300477) announced the initiation of pre-restructuring due to a creditor's bankruptcy reorganization application, with risks of delisting if unsuccessful.

• Wanbang Pharmaceutical Co., Ltd. (301520) reported severe abnormal fluctuations in stock trading, with prices rising over 100% in eight trading days, prompting a warning to investors about potential risks.

• Suzhou Tianmai Thermal Technology Co., Ltd. (301626) confirmed regulatory compliance for its issuance of convertible bonds, with trading set to commence on August 18, 2026.

Other Notable Developments

• Foshan Blue Rocket Electronics Co., Ltd. (301348) announced the acquisition of 60% equity in Chengdu Xinyi Technology Co., Ltd. for 336 million RMB, now a controlling subsidiary.

• ST Meichen Co., Ltd. (300237) disclosed a major litigation matter involving a construction contract dispute, with a claim amount of 13.86 million RMB.

• Yantai Jereh Oilfield Services Group Co., Ltd. (002353) released its semi-annual report, proposing a cash dividend of 1.5 RMB per 10 shares and outlining operational risks.

• Sanquan Food Co., Ltd. (002216) proposed an Employee Stock Ownership Plan to incentivize key personnel, involving up to 11.73 million shares.

These announcements reflect ongoing strategic maneuvers and financial adjustments by companies in various sectors, highlighting both opportunities and challenges in the current market landscape.